SG169362A1 - Treatment or prevention of respiratory viral infections with immunomodulator compounds - Google Patents

Treatment or prevention of respiratory viral infections with immunomodulator compounds

Info

Publication number
SG169362A1
SG169362A1 SG201100671-5A SG2011006715A SG169362A1 SG 169362 A1 SG169362 A1 SG 169362A1 SG 2011006715 A SG2011006715 A SG 2011006715A SG 169362 A1 SG169362 A1 SG 169362A1
Authority
SG
Singapore
Prior art keywords
prevention
treatment
viral infections
respiratory viral
immunomodulator compounds
Prior art date
Application number
SG201100671-5A
Other languages
English (en)
Inventor
Cynthia W Tuthill
Alfred R Rudolph
Alexander A Kolobov
Andrey S Simbirtsev
Aleksandr V Petrov
Original Assignee
Sciclone Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals Inc filed Critical Sciclone Pharmaceuticals Inc
Publication of SG169362A1 publication Critical patent/SG169362A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG201100671-5A 2004-05-14 2005-05-12 Treatment or prevention of respiratory viral infections with immunomodulator compounds SG169362A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57094104P 2004-05-14 2004-05-14

Publications (1)

Publication Number Publication Date
SG169362A1 true SG169362A1 (en) 2011-03-30

Family

ID=35428773

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201100671-5A SG169362A1 (en) 2004-05-14 2005-05-12 Treatment or prevention of respiratory viral infections with immunomodulator compounds

Country Status (17)

Country Link
US (1) US20070087974A1 (fr)
EP (1) EP1748783A4 (fr)
JP (1) JP2007537280A (fr)
KR (1) KR20070012522A (fr)
CN (1) CN1964731A (fr)
AU (1) AU2005244826B2 (fr)
BR (1) BRPI0511107A (fr)
CA (1) CA2566062A1 (fr)
EA (1) EA011954B1 (fr)
IL (1) IL179046A0 (fr)
MX (1) MXPA06013050A (fr)
NO (1) NO20065518L (fr)
NZ (1) NZ551457A (fr)
SG (1) SG169362A1 (fr)
UA (1) UA92586C2 (fr)
WO (1) WO2005112639A2 (fr)
ZA (1) ZA200610454B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8193152B2 (en) 2004-10-27 2012-06-05 The Board Of Regents Of The University Of Texas System Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds
WO2006116053A1 (fr) * 2005-04-22 2006-11-02 Sciclone Pharmaceuticals, Inc. Composes immunomodulateurs favorisant l'efficacite vaccinale
UA96980C2 (ru) 2007-02-13 2011-12-26 Сайклон Фармасютикалс, Инк. Способ уменьшения степени ухудшения состояния, поражения или повреждения слизистой оболочки
RU2007118237A (ru) * 2007-05-17 2008-11-27 ООО "Научно-производственна фирма Верта" (RU) Способ лечения аллергических заболеваний
RU2438694C1 (ru) * 2010-12-23 2012-01-10 Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") Фармацевтическая композиция для лечения вирусных заболеваний
WO2024175759A1 (fr) * 2023-02-24 2024-08-29 Institut National de la Santé et de la Recherche Médicale Acide indole-3-propionique en tant que contributeur important à l'issue d'une infection virale et biomarqueur de la gravité d'une infection virale

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4917888A (en) * 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US4766106A (en) * 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US5122614A (en) * 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5888980A (en) * 1994-06-30 1999-03-30 Bio-Logic Research And Development Corporation Compositions for enhancing immune function
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
RU2229892C2 (ru) * 2001-06-08 2004-06-10 Государственное учреждение "Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии" Способ лечения туберкулеза легких

Also Published As

Publication number Publication date
NO20065518L (no) 2006-11-29
NZ551457A (en) 2009-12-24
EP1748783A2 (fr) 2007-02-07
JP2007537280A (ja) 2007-12-20
EP1748783A4 (fr) 2009-08-05
CA2566062A1 (fr) 2005-12-01
IL179046A0 (en) 2007-03-08
EA200602073A1 (ru) 2007-06-29
ZA200610454B (en) 2009-07-29
MXPA06013050A (es) 2007-03-28
AU2005244826A1 (en) 2005-12-01
WO2005112639A3 (fr) 2006-11-09
WO2005112639A2 (fr) 2005-12-01
CN1964731A (zh) 2007-05-16
KR20070012522A (ko) 2007-01-25
US20070087974A1 (en) 2007-04-19
AU2005244826B2 (en) 2010-07-29
UA92586C2 (ru) 2010-11-25
BRPI0511107A (pt) 2007-11-27
EA011954B1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
AU2003291885A1 (en) Compounds and methods for the treatment or prevention of flavivirus infections
TW200733953A (en) Materials and methods for treating viral infections
GB0612423D0 (en) Therapeutic agents
EA200900156A1 (ru) Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
MX2009006764A (es) Pirimidinonas biciclicas y usos de la misma.
WO2006027628A3 (fr) Derives de naphtalimide en tant qu'agents antiviraux
SG169362A1 (en) Treatment or prevention of respiratory viral infections with immunomodulator compounds
MX2010008921A (es) Derivados de oxazolidinona.
WO2008097599A3 (fr) Doublure antimicrobienne pour brassard de prise de pression artérielle
TN2015000293A1 (en) Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases
WO2005084315A3 (fr) Derives de pyranoindole et utilisation de ceux-ci pour le traitement d'une maladie ou d'une infection provoquee par le virus de l'hepatite c
NZ588655A (en) Treatment of hepatitis c virus infections with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interfer0n-alpha-2a/2b and ribavirin
NO20055512L (no) Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider
IL182710A0 (en) Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds
EP1525216A4 (fr) Therapie combinee pour le traitement d'infection vih
WO2009023356A3 (fr) Matériaux et procédés pour traiter les infections par le virus de la grippe
WO2006076169A3 (fr) Utilisation de composes immunomodulateurs pour le traitement ou la prevention d'infections virales genitales
ZA200800999B (en) Use of N-dibenz (b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy
WO2010019698A3 (fr) Inhibition d'un calicivirus (norovirus)
ATE338545T1 (de) Polymaleinimid-verbindungen und ihre medizinische verwendung